References

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course . Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about (online CE course)
References

Clostridium difficile infection: a review of current and emerging therapies, A Ofosu, Annals of Gastroenterology, 2016. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805733/. Accessed on February 8, 2023.
C Difficile Overview, Cdiff foundation. Available at https://cdifffoundation.org/ Accessed on February 8, 2023.
C difficile infection: Overview, Symptoms, Causes, Risk Factors, and Prevention, Mayo Clinic. Available at https://www.mayoclinic.org/diseases-co nditions/c-difficile/symptoms-causes/syc-20351691?p=1. Accessed on February 8, 2023.
C difficile, Diagnosis and Treatment, Mayo Clinic. Available at https://www.mayoclinic.org/diseases-conditions/c-difficile/diagnosis-treatment/drc-20351697. Accessed on February 8, 2023.
Clostridium difficile infections, Medline Plus, U.S. National Library of Medicine. Available at https://medlineplus.gov/clostridiumdifficileinfections.html. Accessed February 8, 2023.
C. Difficile Infection, Am College of GI (ACG). Available at http://patients.gi.org/topics/c-difficile-infection/. Accessed on February 8, 2023.
Clostridium difficile infection in adults: Clinical manifestations and diagnosis, Kelly C P et al, Uptodate, updated June, 2018. Available at https://www.uptodate.com/contents/clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis#H22. Accessed on February 8, 2023.
Clostridium difficile infections. Centers for Disease Control and Prevention Web site. Available at https://www.cdc.gov/hai/organisms/cdiff/cdiff_infect.html. Accessed on February 8, 2023.
Clostridium difficile infections, CDC, Overview. Available at Centers for Disease Control and Prevention. Clostridium difficile infection. Accessed on February 8, 2023.
Snydman DR, McDermott LA, Jenkins SG, et al. Epidemiologic trends in Clostridium difficile isolate ribotypes in United States from 2010 to 2014. Open Forum Infectious Diseases. 2017;4(suppl_1):S391-S391.
Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346:334.
Schutze GE, Willoughby RE, Committee on Infectious Diseases, American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics. 2013;131;196-200.
McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66:e1.
Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 2015; 313:398.
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372:1539.
Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 209;58:403-410.
Clostridium Difficile Colitis (Antibiotic-Associated Colitis) Dennis Lee MD, MedicineNet. Available at https://www.medicinenet.com/clostridium_difficile_colitis/article.htm#how_is_clostridium_difficile_colitis_treated. Accessed on February 8, 2023.
Tschudin-Sutter S, Kuijper EJ, Durovic A, et al. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin Microbioland Infect. 2018;Mar 2. pii: S1198-743X(18)30195-2.
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. O’Conner JR et al, Gastroenterology, 2009 May;136(6):1913-24. Available at https://www.ncbi.nlm.nih.gov/pubmed/19457419. Accessed on February 8, 2023.

The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins, Chen S et al, Toxins (Basel), 2015 Dec; 7(12): 5254–5267. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690124/. Accessed on February 8, 2023.
Lim SK, Stuart RL, Mackin KE, et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis. 2014;58(12):1723-1730.
Kociolek LK, Gerding DN. Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027. J Clin Microbiol. 2016;54(1):19-24.
Current knowledge on the laboratory diagnosis of Clostridium difficile infection: Review of diagnostic testing: Adrián Martínez-Meléndez, et al,World J Gastroenterol. Mar 7, 2017; 23(9): 1552-1567. Available at https://www.wjgnet.com/1007-9327/full/v23/i9/1552.htm. Accessed February 8, 2023.
Clostridium difficile and C difficile toxin testing, Labtestsonline, AACC. Available at https://labtestsonline.org/tests/clostridium-difficile-and-c-difficile-toxin-testing. Accessed on February 8, 2023.
Clostridium difficile Diagnostic Testing: Quest Diagnostics. Available at https://education.questdiagnostics.com/faq/FAQ136. Accessed on February 8, 2023.
Planche TD, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicenter diagnostic validation study of difficile infection. The Lancet. 2013;13(11):936-945.
Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis, Bai Y et al,Published: October 9, 2017 . Available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185891. Accessed on February 8, 2023.
Package insert TECHLAB® C. DIFF QUIK CHEK COMPLETE®. Available at http://www.alere.com/en/home/product-details/c-diff-quik-chek-complete.html. Accessed on February 8, 2023.
C Diff Quik Chek Complete: product details, Alere. Available at https://www.alere.com/en/home/product-details/c-diff-quik-chek-complete.html. Accessed on February 8, 2023.
The Xpect C difficile Toxin A/B Test: Remel, Product Information. Available at https://www.thermofisher.com/order/catalog/product/R24640. Accessed at February 8, 2023.
The Xpect C difficile Toxin A/B Test: Product PDF, Fisher Sci. Available at https://assets.fishersci.com/TFS-Assets/LSG/manuals/IFU24650.pdf and https://www.fishersci.com/shop/products/xpect-c-difficile-toxin-a-b-test/p-4527869. Accessed on February 8, 2023.
FDA review of C. DIFF QUIK CHEK COMPLETE™ . Available at https://www.accessdata.fda.gov/cdrh_docs/reviews/K082499.pdf. Accessed on February 8, 2023.
Cohen SH, Gerding DN, Johnson S, et al. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455.

New IDSA/SHEA Clostridium Difficile Guidelines, Clin Infect Dis; ePub 2018 Feb 15; McDonald, et al: Published, February 26, 2018. Available at https://www.mdedge.com/idpractitioner/clinical-edge/summary/antimicrobial-resistance/new-idsa/shea-clostridium-difficile. Accessed on February 8, 2023.
McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). [Published online ahead of print February 15, 2018]. Clin Infect Dis. doi:10.1093/cid/cix1085.

New guidelines and studies suggest improved approaches to C. difficile testing, Sherry A. Dunbar, June 21, 2018, MLO. Available at https://www.mlo-online.com/continuing-education/article/13017015/new-guidelines-and-studies-suggest-improved-approaches-to-c-difficile-testing. Accessed on February 8, 2023.
Roecker A, et al, Gastrointestinal Infections and Enterotoxigenic Poisoning: Taken from DiPiro JT, et al, Pharmacotherapy: A Pathophysiologic Approach, 12e New York, NY: McGraw-Hill; Available at https://accesspharmacy.mhmedical.com/content.aspx?bookid=3097§ionid=265903073. Accessed on February 8, 2023.

Multistep algorithm testing accurately identifies C. diff patients who need treatment, Jodie Lee, July 2018, MLO. Available at https://www.mlo-online.com/multistep-algorithm-testing-accurately-identifies-c.diff-patients-who-need-treatment. Accessed on February 8, 2023.
Other References:
Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for the diagnosis, treatment and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-498.
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372:1539.
American Society for Microbiology. A practical guidance document for the laboratory detection of toxigenic
Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 209;58:403-410.
Crobach MJ, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 2016; 22 Suppl 4:S63.
Debast SB, et al, European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20 Suppl 2:1.
Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013; 173:1359.
Bulusu M, et al, Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol 2000; 95:3137.
Fekety R, et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24:324.
Goldenberg SD, Cliff PR, Smith S, et al. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 2010; 74:48.
Novak-Weekley SM, et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010; 48:889.
Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol 2008; 46:3686.
Gade R, Turett G. The utility of repeated stool toxin testing for diagnosing Clostridium difficile colitis. South Med J 2009; 102:1007
Kufelnicka AM, Kirn TJ. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis 2011; 52:1451.
Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108:478.
Eastwood K, et al, Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009; 47:3211.
Fenner L, et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008; 46:328.
Wilkins TD, Lyerly DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 2003; 41:531.
Swindells J, et al, Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010; 48:606.